Riverhead Capital Management’s Teladoc Health TDOC Stock Holding History

Riverhead Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$3.18M	Sell	46,938 -12,669	-21%	-$834K	0.12%	224
2019 Q2	$3.96M	Buy	59,607 +11,453	+24%	+$668K	0.15%	189
2019 Q1	$2.68M	Buy	48,154 +763	+2%	+$46.6K	0.11%	253
2018 Q4	$2.35M	Buy	47,391 +3,148	+7%	+$193K	0.11%	255
2018 Q3	$3.82M	Buy	44,243 +857	+2%	+$61.1K	0.14%	196
2018 Q2	$2.52M	Sell	43,386 -8,614	-17%	-$421K	0.1%	267
2018 Q1	$2.1M	Buy	52,000 +20,000	+63%	+$755K	0.09%	273
2017 Q4	$1.11M	Hold	32,000	–	–	0.05%	402
2017 Q3	$1.06M	Buy	+32,000	New	+$1.05M	0.05%	388

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Riverhead Capital Management's TDOC Position: Q3 2019 in Review

Riverhead Capital Management reduced its Teladoc Health (TDOC) stake by 21% in Q3 2019, selling an estimated $834K and leaving 46,938 shares worth $3.18M. The position accounts for 0.12% of the portfolio, ranked #224.

Riverhead Capital Management first reported a position in TDOC in Q3 2017 and has held it in 9 quarters since. The position peaked at $3.96M in Q2 2019. 377 funds tracked by Wall St. Rank hold TDOC as of Q3 2019.

Riverhead Capital Management held 46,938 shares of Teladoc Health worth $3.18M as of Q3 2019.
Riverhead Capital Management sold 12,669 Teladoc Health shares in Q3 2019, an estimated $834K.
Teladoc Health made up 0.12% of Riverhead Capital Management's portfolio in Q3 2019, its #224 holding.
Riverhead Capital Management first reported a position in Teladoc Health in Q3 2017 and has held it in 9 quarters since.
Riverhead Capital Management's Teladoc Health position peaked at $3.96M in Q2 2019.
377 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.